UBS Group’s Vicor VICR Stock Holding History

UBS Group’s Portfolio VICR Stock Details VICR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-30,000	Closed	-$2.77M	–	9509
2020 Q4	$2.77M	Buy	+30,000	New	+$2.52M	﹤0.01%	3073

Other funds holding VICR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

UBS Group's VICR Position: Q2 2026 in Review

UBS Group increased its Vicor (VICR) stake by 70% in Q2 2026, buying an estimated $17.6M and bringing the position to 156,855 shares worth $59.6M. The position accounts for 0.01% of the portfolio, ranked #1568.

UBS Group first reported a position in VICR in Q4 2014 and has held it in 47 quarters since. 515 funds tracked by Wall St. Rank hold VICR as of Q2 2026.

UBS Group held 156,855 shares of Vicor worth $59.6M as of Q2 2026.
UBS Group bought 64,432 Vicor shares in Q2 2026, an estimated $17.6M.
Vicor made up 0.01% of UBS Group's portfolio in Q2 2026, its #1568 holding.
UBS Group first reported a position in Vicor in Q4 2014 and has held it in 47 quarters since.
515 funds tracked by Wall St. Rank held Vicor as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.